跳至主要内容
临床试验/IRCT2016041317827N1
IRCT2016041317827N1Other未知

A randomized clinical trial on comparison of efficacy of Glibanclamide and insulin on Gestational Diabetes and outcome of pregnancy

Vice Chancellor Of Research, Shiraz University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
Other
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 40 years(—)
性别
Female

入选标准

  • Maternal age 20-40 years old; singleton pregnancy; gestational age and diagnosis of gestational diabetes will be given during pregnancy; healthy mothers with no renal diseases liver diseases and overt diabetes.
  • Exclusion criteria: If the blood glucose is not controlled by the does of 15 mg glibanclamid they will be shifted to Insulin and will be excluded the study.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor Of Research, Shiraz University of Medical Sciences

相似试验